Rare diseases
Investigational molecules
Locations
7 Times Square Suite 2503, 10036-6550, United States
Sellas Life Sciences Group Inc. focuses on clinical research in acute myeloid leukemia, with interest centered on patients in second complete remission and second complete remission with incomplete platelet recovery. The sponsor’s trial activity is directed toward treatment settings where disease control remains a major clinical challenge.
The research landscape is concentrated in blood cancer care, with attention to patients whose disease has returned after earlier treatment and who remain eligible for additional therapeutic intervention.
Sellas Life Sciences Group Inc. runs clinical trials in conditions such as Acute myeloid leukaemia (in remission), among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
